Introducing Sublingual Semaglutide Tablets! An INJECTION-FREE option for GLP-1 compounded preparations. Ask your pharmacist about sublingual semaglutide tablets today!

rev-pic

OUR EXCITING VISION

Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative and quality pharmacy preparations and services through “industry best” patient care and solutions for customers.

InnovationCompounding-9835
inno_1
inno_2
inno_4

Revelation Pharma PGY1 Community-Based Pharmacy Residency Purpose

PGY1 residency programs build upon Doctor of Pharmacy education and outcomes to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives.  Residents who successfully complete PGY1 residency programs will be skilled in diverse patient care, practice management, leadership, and education, and be prepared to provide patient care, seek board certification in pharmacotherapy (i.e., BCPS), and pursue advanced education and training opportunities including postgraduate year two (PGY2) residencies.

In addition to patient care experiences commonly encountered in community-based pharmacy settings, the Revelation Pharma PGY1 Community-Based Pharmacy Residency offers additional training opportunities in sterile and nonsterile compounding, clinical research and formulation development, business administration, and pharmacy advocacy.  The Revelation Pharma PGY1 Community-Based Pharmacy Residency prepares pharmacist practitioners to serve as highly qualified independent practitioners who are able to:

  • demonstrate expertise in the field of sterile and nonsterile compounding;
  • optimize patient outcomes through personalized medication management and utilization of novel formulations to meet individualized needs of patients;
  • develop, create, implement, and adhere to sophisticated quality assurance programs;
  • navigate the intricate regulatory landscape surrounding compounding and ensure adherence to guidelines set by the FDA, USP, and PCAB;
  • identify and implement efficiencies to increase pharmacy productivity while controlling costs; and
  • serve in managerial roles within community pharmacies.
innovation-hex

About Innovation Compounding

Innovation Compounding is a compounding pharmacy that supports over 7,000 prescribers, 80,000+ patients and annually provides 100,000 prescriptions across the nation. We commit to individualized pharmaceutical care through being Relentless in our drive for personalized medicine, Compassionate toward our patients and doctors, as well as being a Wellness Advocate for our patients’ lives and state of wellbeing. Innovation Compounding Pharmacy is part of a network of 503A and 503B compounding pharmacies within the Revelation Pharma Network – which work together as a collective team to serve patients.  Revelation Pharma’s Innovation Compounding Pharmacy’s therapeutic areas include allergy immunotherapy, dermatology/cosmeceutical medicine, functional medicine, geriatrics, hospice/long-term care, infectious disease, intravenous/intramuscular nutrition, men’s health, pain management, pediatrics, veterinary, weight management, and women’s health.

Learning Experiences

  • Orientation
  • Longitudinal
    • Business Administration
    • Innovation Compounding Patient Care
    • Leader Development and Pharmacy Advocacy
    • Primary Care Patient Care
    • Quality Assurance, Quality Compliance, and Regulatory Affairs
    • Research Project
    • Staffing at Innovation Compounding Pharmacy (four days each month)
    • Texas Tech University Health Sciences Center Teaching and Learning Curriculum Program with Teaching Certificate
  • Rotational
    • Clinical Liaison Consultation Patient Care
    • Formulation Research and Development
    • Pharmacy Logistics: Manager’s Perspective
    • USP 795 and USP 800 Nonsterile Compounding
    • USP 797 and USP 800 Sterile Compounding
    • Elective learning experiences will be developed based on resident interest and preceptor availability.

Stipend and Benefits

  • Stipend: $54,000 for a 52-week appointment term beginning the first week of July
  • Educational conference stipend: $5,000
  • Paid time off: 40 hours
  • Sick time: up to 48 hours
  • Seven holidays and one floating holiday
  • Health, dental, vision, life insurance, and supplemental benefits
  • 401K retirement plan
  • Employee Assistance Program
  • Travel Assistance Program

Informative Webinars

Are you ready to take your pharmacy career to the next level? Join us for an informative webinar that offers an overview of the Revelation Pharma – Innovation Compounding PGY1 Community-Based Pharmacy Residency Program. Whether you’re considering applying or just curious about this residency program, this webinar will provide the information you need to make an informed decision. Click on a webinar link below to register and secure your spot. We look forward to seeing you and helping you embark on this exciting career path!

ASHP Midyear Residency Showcase

  • Session: December 10, 2024 (Tuesday ): 1 PM to 4 PM
  • Booth Number: 6068

Application

  • ASHP Program Code: 34812
  • PhORCAS Code: 315615
  • Application package (via PhORCAS):
    - Cover letter
    Curriculum vitae
    - Three letters of recommendation
    - Pharmacy school transcripts

Leadership Team

B_Sucher_Headshot_1

Brandon Sucher

Residency Program Director

Elaina-Baaklini400

Elaina Baaklini

Residency Program Coordinator

Current Residents

Katherine-Moutis400

Katherine Moutis

Resident

Kayla-Garris400

Kayla Garris

Resident

Commitment to Diversity

Revelation Pharma is committed to creating and maintaining a workplace in which all employees have an opportunity to participate and contribute to the success of the business and are valued for their skills, experience, and unique perspectives. This commitment is embodied in company policy and the way we do business at Revelation Pharma and is an important principle of sound business management.